Recombinant IL13 (Tralokinumab Biosimilar) antibody

Catalog No. ABIN7581481

The Human Monoclonal anti-IL13 (Tralokinumab Biosimilar) antibody has been validated for ELISA, BLI, FACS, Func and SPR. It is suitable to detect IL13 (Tralokinumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL13 (Tralokinumab Biosimilar) antibody (ABIN7581481)

Target: IL13 (Tralokinumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL13 (Tralokinumab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IL13 (Tralokinumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IL-13 Reference Antibody (tralokinumab)

Characteristics: Anti-IL-13 Reference Antibody (tralokinumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IL13 (Tralokinumab Biosimilar)

Target: IL13 (Tralokinumab Biosimilar)

Alternative Name: IL-13 (Tralokinumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P35225